Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
According to the phase 3 double-blind clinical trial published in the New England Journal of Medicine, adults with obesity lost an average of 19.5% to 20.9% of body weight on higher tirzepatide doses
Most cases resolve
Keep the flow gentle from start to finish a hard stream can stress fragile peptide chains
Weight-loss medication is a serious medical treatment designed to support people who meet strict eligibility requirements set by our medical team
Your existing physician may have clinical context that's directly relevant to whether GLP-1 treatment is a good fit for you and that conversation is always worth having before enrolling in any online program
A separate Phase 2a trial showed significant liver fat reduction in patients with MASLD/MASH
US$ 23.81
US$ 29.41
US$ 24.68
US$ 24.48
US$ 22.21
